Allele Symbol Allele Name Allele ID |
Gfi1+ wild type MGI:2433063 |
||||||||||||||||||||||||||||||||||||||||||||
Summary |
10 genotypes
|
|
|
♀ | phenotype observed in females |
♂ | phenotype observed in males |
N | normal phenotype |
|
|
♀ | phenotype observed in females |
♂ | phenotype observed in males |
N | normal phenotype |
N |
• mice exhibit normal NK cell accessory cells
|
• NK cell maturation is blocked at the double positive stage unlike in wild-type mice
|
• mice exhibit an accumulation of atypical myeloid precursors in the bone marrow compared with wild-type mice
|
• in the blood, spleen, bone marrow, liver, lungs and lymph nodes
|
• hyporesponsive towards YCA-1 target cells in vitro and MHC-I-deficient splenocytes in vivo
• hyporesponsive towards stimulation of NK1.1-, NKp46- or NKG2D- and Ly49D-activatng receptors
• transplant experiments confirm that NK cell hyporeactivity involves a cell-extrinsic factor
• NK cells exhibit higher rates of proliferation and poorer survival compared with wild-type cells
• however, responsiveness to PMA and ionomycin stimulation is normal and NK cells regain full reactivity in a wild-type environment
|
• after stimulation with YAC-1 target cells
|
• NK cell maturation is blocked at the double positive stage unlike in wild-type mice
|
• mice exhibit an accumulation of atypical myeloid precursors in the bone marrow compared with wild-type mice
|
• in the blood, spleen, bone marrow, liver, lungs and lymph nodes
|
• hyporesponsive towards YCA-1 target cells in vitro and MHC-I-deficient splenocytes in vivo
• hyporesponsive towards stimulation of NK1.1-, NKp46- or NKG2D- and Ly49D-activatng receptors
• transplant experiments confirm that NK cell hyporeactivity involves a cell-extrinsic factor
• NK cells exhibit higher rates of proliferation and poorer survival compared with wild-type cells
• however, responsiveness to PMA and ionomycin stimulation is normal and NK cells regain full reactivity in a wild-type environment
|
• after stimulation with YAC-1 target cells
|
• after stimulation with YAC-1 target cells
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
severe congenital neutropenia | DOID:0050590 |
OMIM:PS202700 |
J:182679 |
|
|
♀ | phenotype observed in females |
♂ | phenotype observed in males |
N | normal phenotype |
• proliferative expansion of granulomonocytic progenitors
|
• proliferative expansion of granulomonocytic progenitors
|
|
|
♀ | phenotype observed in females |
♂ | phenotype observed in males |
N | normal phenotype |
• inner hair cells retain kinocilia at P15 unlike in wild-type cells where kinocilia are retracted by this time
|
• widespread loss of outer hair cells by P15
|
• by P90
|
• progressive degeneration associated with sporadic fusion of stereocilia on some of the remaining bundles by P90
|
• increase in expression of pro-apoptotic factors in outer hair cells at P12 and P15
|
• rapid progressive hearing loss beginning at P22 with no measurable hearing by 3 months of age
|
• inner hair cells retain kinocilia at P15 unlike in wild-type cells where kinocilia are retracted by this time
|
• widespread loss of outer hair cells by P15
|
• by P90
|
• progressive degeneration associated with sporadic fusion of stereocilia on some of the remaining bundles by P90
|
• increase in expression of pro-apoptotic factors in outer hair cells at P12 and P15
|
• inner hair cells retain kinocilia at P15 unlike in wild-type cells where kinocilia are retracted by this time
|
• increase in expression of pro-apoptotic factors in outer hair cells at P12 and P15
|
|
|
♀ | phenotype observed in females |
♂ | phenotype observed in males |
N | normal phenotype |
N |
• normal hearing thresholds at 3 months of age
|
|
|
♀ | phenotype observed in females |
♂ | phenotype observed in males |
N | normal phenotype |
• a 6.5 dB shift in threshold is detected at 16kHz in 3-6 month-old mice compared to controls; at 9-10 months, hearing thresholds are comparable to controls
|
|
|
♀ | phenotype observed in females |
♂ | phenotype observed in males |
N | normal phenotype |
• of all pIpC-treated mice faster than control mice
|
• all pIpC-treated mice die of myeloproliferative disorder accompanied by an expansion of myeloid cells in the bone marrow, an infiltration of myeloid cells in the spleen, and the appearance of blast cells in the blood faster than control mice
|
• all pIpC-treated mice die of myeloproliferative disorder accompanied by an expansion of myeloid cells in the bone marrow, an infiltration of myeloid cells in the spleen, and the appearance of blast cells in the blood faster than control mice
|
|
|
♀ | phenotype observed in females |
♂ | phenotype observed in males |
N | normal phenotype |
• no viable homozygotes are produced
|
|
|
♀ | phenotype observed in females |
♂ | phenotype observed in males |
N | normal phenotype |
|
|
♀ | phenotype observed in females |
♂ | phenotype observed in males |
N | normal phenotype |
N |
• normal hearing thresholds at 3 months of age
|
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 03/25/2025 MGI 6.24 |
![]() |
|